Chief Executive Officer
Professional background: Magnus Corfitzen (born 1975) has extensive experience from investing, building and growing Life Science companies in various roles including operational activities or investment responsibilities for public and private biotech and medtech companies. Magnus Corfitzen also has board experience from a number of Life Science companies. Magnus Corfitzen has previously been Investment Director at Sunstone Capital A/S and Investment Director at Vækstfonden (the Danish Growth Fund). Prior to entering the healthcare venture capital field he was a Portfolio Manager at Danske Capital with responsibility for investments into listed biotech and medtech companies and he started his career at McKinsey & Company.
Education: M.Sc. in Mathematical Economics from the University of Aarhus, Denmark, which included studies at Harvard University, US.
Other ongoing assignments: Board member of Ascelia Incentive AB. CEO of Oncoral Pharma ApS.
Holdings in Ascelia: View holdings